MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer

NCT04729543 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Melanoma, Uveal
Head and Neck Cancer

Interventions

BIOLOGICAL: Adoptive therapy with autologous MC2 TCR T cells

Sponsor

Erasmus Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]